IRIS
PIVONELLO, ROSARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 17.591
NA - Nord America 15.723
EU - Europa 10.996
SA - Sud America 2.226
AF - Africa 423
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 13
Totale 46.995
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.040
SG - Singapore 7.771
RU - Federazione Russa 5.239
CN - Cina 3.449
VN - Vietnam 2.983
BR - Brasile 1.756
IT - Italia 1.594
HK - Hong Kong 1.470
DE - Germania 834
FR - Francia 609
FI - Finlandia 535
NL - Olanda 512
SE - Svezia 388
CA - Canada 375
BD - Bangladesh 356
IE - Irlanda 321
GB - Regno Unito 301
IN - India 287
UA - Ucraina 259
JP - Giappone 230
MX - Messico 178
AR - Argentina 171
KR - Corea 145
IQ - Iraq 125
TR - Turchia 106
CI - Costa d'Avorio 101
PL - Polonia 93
EC - Ecuador 89
ID - Indonesia 88
ZA - Sudafrica 87
PH - Filippine 84
ES - Italia 79
TH - Thailandia 70
CO - Colombia 55
PK - Pakistan 51
TW - Taiwan 46
KE - Kenya 45
AT - Austria 40
VE - Venezuela 36
UZ - Uzbekistan 33
CL - Cile 32
EG - Egitto 32
TN - Tunisia 31
JO - Giordania 30
MA - Marocco 30
PY - Paraguay 30
IL - Israele 28
SA - Arabia Saudita 28
AE - Emirati Arabi Uniti 27
LT - Lituania 27
IR - Iran 25
MY - Malesia 23
BE - Belgio 21
CR - Costa Rica 21
CZ - Repubblica Ceca 20
JM - Giamaica 20
UY - Uruguay 19
DZ - Algeria 18
PE - Perù 18
HN - Honduras 17
LB - Libano 17
NP - Nepal 17
PT - Portogallo 17
BO - Bolivia 16
AU - Australia 15
ET - Etiopia 14
AZ - Azerbaigian 13
RO - Romania 13
CH - Svizzera 11
NI - Nicaragua 10
OM - Oman 10
SY - Repubblica araba siriana 10
TT - Trinidad e Tobago 10
DO - Repubblica Dominicana 9
PA - Panama 9
LV - Lettonia 8
PS - Palestinian Territory 8
GR - Grecia 7
KZ - Kazakistan 7
NG - Nigeria 7
AF - Afghanistan, Repubblica islamica di 6
AL - Albania 6
GT - Guatemala 6
HU - Ungheria 6
KW - Kuwait 6
SN - Senegal 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BB - Barbados 5
BG - Bulgaria 5
BH - Bahrain 5
BY - Bielorussia 5
HR - Croazia 5
KG - Kirghizistan 5
MD - Moldavia 5
RS - Serbia 5
SI - Slovenia 5
BF - Burkina Faso 4
BS - Bahamas 4
BW - Botswana 4
Totale 46.859
Salva come PNG Salva come JPEG
Città #
Singapore 3.725
San Jose 2.756
Hong Kong 1.435
Moscow 1.274
Chandler 1.124
Ashburn 1.068
Ho Chi Minh City 892
Beijing 862
Hanoi 624
Hefei 611
Santa Clara 560
Millbury 473
The Dalles 432
Amsterdam 426
Naples 406
Lauterbourg 391
Los Angeles 377
Princeton 303
Munich 283
Jacksonville 277
Nanjing 259
New York 235
Buffalo 229
Wilmington 199
Tokyo 196
Boston 170
São Paulo 165
Dallas 162
Redondo Beach 149
Napoli 138
Da Nang 131
Des Moines 124
Ottawa 122
Helsinki 120
Turku 116
Council Bluffs 108
Orem 106
Seoul 106
Haiphong 105
Houston 98
Frankfurt am Main 97
Montreal 90
Atlanta 85
Seattle 84
Woodbridge 84
Chicago 82
Boardman 79
Lawrence 79
Rome 79
Nanchang 77
Warsaw 75
Mexico City 72
San Francisco 65
Toronto 64
Falkenstein 61
Denver 59
Hebei 58
Brooklyn 56
Phoenix 56
Chennai 54
Rio de Janeiro 54
Nuremberg 52
Tianjin 51
London 50
Biên Hòa 48
Johannesburg 46
Milan 45
Stockholm 45
Hải Dương 43
Shenyang 43
Baghdad 42
Manchester 42
Nairobi 42
Poplar 42
Changsha 39
Ann Arbor 37
Can Tho 35
Curitiba 35
Norwalk 35
Shanghai 34
Jiaxing 33
Memphis 33
Ankara 32
Brasília 32
Belo Horizonte 31
Kochi 31
Kronberg 31
Quito 30
Tashkent 30
Porto Alegre 29
San Mateo 29
Columbus 28
Dhaka 28
Falls Church 28
New Delhi 28
Ninh Bình 28
Mumbai 27
Dublin 26
Guayaquil 26
Guangzhou 25
Totale 24.238
Salva come PNG Salva come JPEG
Nome #
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 539
Long-term high-dose l-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial 352
Effects of Chrono-Exercise and Chrono-Nutrition on Muscle Health: Understanding the Molecular Mechanisms Activated by Timed Exercise and Consumption of Proteins and Carbohydrates 248
Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas 234
Medical consequences of acromegaly: what are the effects of biochemical control? 222
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 218
Spot-light on microbiota in obesity and cancer 212
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 199
Growth hormone, prolactin, and sexuality. 192
Exposure to artificial light at night: A common link for obesity and cancer? 188
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 185
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 180
The role of vitamin D in male fertility: A focus on the testis 180
The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. 179
Effect of the acute administration of the Dopamine Agonist Cabergoline on glucose tolerance and Insuline Sensitivity in patient with obesity. 176
1,25‑Dihydroxyvitamin D3 mitigates the adipogenesis induced by bisphenol A in 3T3-L1 and hAMSC through miR-27-3p regulation 175
Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis. 175
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study 171
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease 171
Effect of antioxidants on semen parameters in men with oligo-astheno-teratozoospermia: a network meta-analysis 170
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 170
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 170
Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months. 166
Association between vitamin D and sperm parameters: Clinical evidence 163
Flavor perception test: evaluation in patients with Kallmann syndrome 162
MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma 161
Bisphenol A: An emerging threat to female fertility 161
Severe systemic complications of acromegaly 159
Circulating myomiRNAs as biomarkers in patients with Cushing's syndrome 158
Cardiovascular consequences of early-onset growth hormone excess 158
Correlation between Morphometric parameters and chromatin fragmentation in spermatozoa of Canis familiaris. 158
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 158
The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico-subcortical Regions. 157
Reduced bone mineral density in glycogen storage disease type III: Evidence for a possible connection between metabolic imbalance and bone homeostasis 157
Selenium supplementation modulates apoptotic processes in thyroid follicular cells 157
Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women's Endocrinology 155
Neuropsychiatric disorders in Cushing's syndrome. 154
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 153
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 153
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 153
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 153
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 153
Circadian rhythm of glucocorticoid administration entrains clock genes in immune cells: a DREAM trial ancillary study 153
Hypertension in acromegaly and in the normal population: prevalence and determinants 151
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 151
Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas 151
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 150
The role of melatonin in the molecular mechanisms underlying metaflammation and infections in obesity: A narrative review 150
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 149
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma 148
Investigational drugs for the treatment of acromegaly: new agents to transform therapy 147
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 147
Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly 147
Air pollution and female fertility: A systematic review of literature 146
The effect of FT500 Plus® on ovarian stimulation in PCOS women 145
Acromegaly and the cardiovascular system 144
Pathophysiology of diabetes mellitus in Cushing's syndrome. 144
The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center. 144
Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. 143
The environment and male reproduction: The effect of cadmium exposure on reproductive functions and its implication in fertility 143
Shedding new light on female fertility: The role of vitamin D 143
Fertility in Acromegaly: a single center experience on female patients during active disease and after disease remission 142
Cardiac effect of thyrotoxicosis in acromegaly 142
High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study 142
CORTISOL CIRCADIAN RHYTHM AND INSULIN RESISTANCE IN MUSCLE: EFFECT OF DOSING AND TIMING OF HYDROCORTISONE EXPOSURE ON INSULIN SENSITIVITY IN SYNCHRONIZED MUSCLE CELLS 142
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 141
Severe impact of late diagnosis of congenital adrenal hyperplasia on gender identity, sexual orientation and function: case report and review of the literature 140
Impact of Somatostatin Analogs vs. Surgery on glucose metabolism in acromegaly: Results of a 5 years observational, open, prospective study 140
Acromegalic axial arthropathy: a clinical case-control study 140
New perspectives in the medical treatment of acromegaly 140
Cushing's syndrome: aftermath of the cure. 140
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 139
Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit 139
Erratum to: The treatment with pasireotide in Cushing’s disease: effects of long–term treatment on tumor mass in the experience of a single center (Endocrine, (2015), 50, (725-740) DOI 10.1007/s12020-015-0557-2) 139
The Treatment of Cushing's Disease. 138
Adverse events associated with somatostatin analogs in acromegaly. 138
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 138
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients 138
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 138
The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology 138
Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials 138
17 beta hyrossisteroid dehydrogenase type 3 deficiency : a new case of a rare disease with uncommon gene mutation 137
The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas 136
Tumor necrosis factor-alpha increases after corticotropin-releasing hormone administration in Cushing's disease. In vivo and in vitro studies. 135
Evaluation of morphometric parameters and chromatin integrity in the sperm of stallion food supplemented with Maca. 135
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 134
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system. 134
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas 134
Cabergoline counteracts adipose and skeletal muscle lipid accumulation: A novel therapeutic approach to obesity? 133
The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. 133
[Chronic kidney disease: fertility and sexuality] 133
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 132
Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment 132
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure 132
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 132
Effect of Cabergoline on Metabolism in Prolactinomas. 132
Metabolic alterations and cardiovascular outcomes of cortisol excess 132
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life 132
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 131
The role of somatostatin analogs in the management of hepatocellular carcinoma 130
Totale 15.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.214 37 7 10 25 54 215 29 61 372 120 376 908
2022/20232.709 409 227 75 213 329 262 27 230 374 414 112 37
2023/20241.766 86 271 239 142 80 115 49 190 26 36 313 219
2024/202511.809 632 758 99 95 252 584 1.326 761 859 1.053 4.298 1.092
2025/202624.433 2.578 1.855 2.431 2.103 4.015 917 2.936 1.403 3.107 1.399 736 953
2026/20271.334 1.334 0 0 0 0 0 0 0 0 0 0 0
Totale 47.638